Skip to main content

Array Technologies Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Array Technologies Inc

Current Price

$8.73

+1.87%

GoodMoat Value

$38.15

337.0% undervalued
Profile
Valuation (TTM)
Market Cap$1.33B
P/E-10.43
EV
P/B
Shares Out152.85M
P/Sales1.11
Revenue$1.21B
EV/EBITDA57.08

Array Technologies Inc (ARRY) Financial Statements

ARRY Financial Data

EBITDA$33.21M
Revenue (TTM)$1.21B
Gross Profit (TTM)$285.13M
Gross Margin
Operating Margin-2.24%
ROE
ROA-4.61%
Debt/Equity
Current Ratio2.31
FCF$79.81M
FCF Yield5.98%
Piotroski F-Score
Rev/Share (TTM)$7.88
50-Day MA$7.43
200-Day MA$8.46
Shares Outstanding0.15B

ARRY Computed Insights

FCF$79.81M
FCF Growth Rate-23.05%
EPS Growth (CAGR)50.00%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

ARRY Financial Statements & Data

Array Technologies Inc (ARRY) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Array Technologies Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $1.21B. Gross profit (TTM) is $285.13M. EBITDA is $33.21M. Earnings per share (EPS) is $-0.73. The P/E ratio is -10.43. Market capitalization is $1.33B.

Free cash flow (FCF) is $79.81M. FCF growth rate is -23.05%. EPS growth CAGR is 50.00%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Array Technologies Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.